325 related articles for article (PubMed ID: 10582344)
1. Regulation of erythroid 5-aminolevulinate synthase expression during erythropoiesis.
Sadlon TJ; Dell'Oso T; Surinya KH; May BK
Int J Biochem Cell Biol; 1999 Oct; 31(10):1153-67. PubMed ID: 10582344
[TBL] [Abstract][Full Text] [Related]
2. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H
Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140
[TBL] [Abstract][Full Text] [Related]
3. Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia.
Fujiwara T; Okamoto K; Niikuni R; Takahashi K; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Nakamura Y; Nakajima M; Tanaka T; Harigae H
Biochem Biophys Res Commun; 2014 Nov; 454(1):102-8. PubMed ID: 25450364
[TBL] [Abstract][Full Text] [Related]
4. Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia.
Bottomley SS; May BK; Cox TC; Cotter PD; Bishop DF
J Bioenerg Biomembr; 1995 Apr; 27(2):161-8. PubMed ID: 7592563
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the murine erythroid-specific 5-aminolevulinate synthase gene.
Kramer MF; Gunaratne P; Ferreira GC
Gene; 2000 Apr; 247(1-2):153-66. PubMed ID: 10773455
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemia.
Kaneko K; Furuyama K; Fujiwara T; Kobayashi R; Ishida H; Harigae H; Shibahara S
Haematologica; 2014 Feb; 99(2):252-61. PubMed ID: 23935018
[TBL] [Abstract][Full Text] [Related]
7. Histone acetyltransferase p300 regulates the transcription of human erythroid-specific 5-aminolevulinate synthase gene.
Han L; Lu J; Pan L; Wang X; Shao Y; Han S; Huang B
Biochem Biophys Res Commun; 2006 Sep; 348(3):799-806. PubMed ID: 16904069
[TBL] [Abstract][Full Text] [Related]
8. A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia.
Bekri S; May A; Cotter PD; Al-Sabah AI; Guo X; Masters GS; Bishop DF
Blood; 2003 Jul; 102(2):698-704. PubMed ID: 12663458
[TBL] [Abstract][Full Text] [Related]
9. Anti-Correlation between the Dynamics of the Active Site Loop and C-Terminal Tail in Relation to the Homodimer Asymmetry of the Mouse Erythroid 5-Aminolevulinate Synthase.
Na I; Catena D; Kong MJ; Ferreira GC; Uversky VN
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29958424
[TBL] [Abstract][Full Text] [Related]
10. Molecular regulation of 5-aminolevulinate synthase. Diseases related to heme biosynthesis.
May BK; Bhasker CR; Bawden MJ; Cox TC
Mol Biol Med; 1990 Oct; 7(5):405-21. PubMed ID: 2095458
[TBL] [Abstract][Full Text] [Related]
11. 5-Aminolevulinate synthase in sideroblastic anemias: mRNA and enzyme activity levels in bone marrow cells.
Bottomley SS; Healy HM; Brandenburg MA; May BK
Am J Hematol; 1992 Oct; 41(2):76-83. PubMed ID: 1415186
[TBL] [Abstract][Full Text] [Related]
12. Deficient heme and globin synthesis in embryonic stem cells lacking the erythroid-specific delta-aminolevulinate synthase gene.
Harigae H; Suwabe N; Weinstock PH; Nagai M; Fujita H; Yamamoto M; Sassa S
Blood; 1998 Feb; 91(3):798-805. PubMed ID: 9446639
[TBL] [Abstract][Full Text] [Related]
13. Erythroid 5-aminolevulinate synthase and X-linked sideroblastic anemia.
Ferreira GC
J Fla Med Assoc; 1993 Jul; 80(7):481-3. PubMed ID: 8089650
[TBL] [Abstract][Full Text] [Related]
14. Erythroid 5-aminolevulinate synthase, ferrochelatase and DMT1 expression in erythroid progenitors: differential pathways for erythropoietin and iron-dependent regulation.
Zoller H; Decristoforo C; Weiss G
Br J Haematol; 2002 Aug; 118(2):619-26. PubMed ID: 12139757
[TBL] [Abstract][Full Text] [Related]
15. Heme deficiency in erythroid lineage causes differentiation arrest and cytoplasmic iron overload.
Nakajima O; Takahashi S; Harigae H; Furuyama K; Hayashi N; Sassa S; Yamamoto M
EMBO J; 1999 Nov; 18(22):6282-9. PubMed ID: 10562540
[TBL] [Abstract][Full Text] [Related]
16. Intron 1 GATA site enhances ALAS2 expression indispensably during erythroid differentiation.
Zhang Y; Zhang J; An W; Wan Y; Ma S; Yin J; Li X; Gao J; Yuan W; Guo Y; Engel JD; Shi L; Cheng T; Zhu X
Nucleic Acids Res; 2017 Jan; 45(2):657-671. PubMed ID: 28123038
[TBL] [Abstract][Full Text] [Related]
17. Hypoxic induction of human erythroid-specific δ-aminolevulinate synthase mediated by hypoxia-inducible factor 1.
Zhang FL; Shen GM; Liu XL; Wang F; Zhao HL; Yu J; Zhang JW
Biochemistry; 2011 Feb; 50(7):1194-202. PubMed ID: 21207956
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia.
Fujiwara T; Harigae H
Free Radic Biol Med; 2019 Mar; 133():179-185. PubMed ID: 30098397
[TBL] [Abstract][Full Text] [Related]
19. The role of the erythroid-specific delta-aminolevulinate synthase gene expression in erythroid heme synthesis.
Meguro K; Igarashi K; Yamamoto M; Fujita H; Sassa S
Blood; 1995 Aug; 86(3):940-8. PubMed ID: 7620186
[TBL] [Abstract][Full Text] [Related]
20. Human delta-aminolevulinate synthase: assignment of the housekeeping gene to 3p21 and the erythroid-specific gene to the X chromosome.
Bishop DF; Henderson AS; Astrin KH
Genomics; 1990 Jun; 7(2):207-14. PubMed ID: 2347585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]